Institute of Metagenomics and Microbial Technologies (IMMT) is driven by the belief that the multidisciplinary research of composition and complex interaction within microbial communities will help to prevent and cure diseases caused by antimicrobial resistant (AMR) bacteria. Patients infected by such bacteria are generally at increased risk of worse clinical outcomes and death and consume more healthcare resources than those infected by nonresistant ones (source: WHO). Since AMR infections are globally increasing this has become a growing problem of worldwide proportions. The IMMT team of researchers lead by PI dr. Ales Lapanje is keen to get different solutions to mitigate problems associated with AMR bacteria. Our team members has more than 10 years of experience in the field of molecular microbial ecology, supported by more than 40 independent academic and industrial projects. Based on understanding the functioning of microbial communities we are now ready to make new steps in finding more effective solutions for in fighting against AMR bacteria. We approach this problem by using functional metagenomics to obtain antimicrobially active agents for which we develop methods for its delivery to specific microbial targets. IMMT is organized as a research SME with the only goal to help humanity fighting against bacterial infections. For more information, please visit www.immt.eu